哥伦比亚分型在局灶节段性肾小球硬化中的效用:病理变异型的肾脏预后与治疗反应
该研究从日本10个肾脏病中心提取201例FSGS患者,分析哥伦比亚分型各病理变异型与复合肾脏终点(血肌酐翻倍和/或进展至终末期肾病)的差异。结果显示塌陷型预后显著差于非特殊型(HR 3.71,P=0.005),尖端型无患者达到终点;细胞型在未用激素/免疫抑制亚组中预后差于非特殊型(HR 5.10,P=0.040),但激素/免疫抑制亚组中无差异。哥伦比亚分型有助于预测日本FSGS患者肾脏预后。
要点
- 塌陷型FSGS肾脏预后显著差于非特殊型(HR 3.71,P=0.005)。
- 尖端型患者无一人达到复合肾脏终点。
- 细胞型未用激素/免疫抑制时预后差(HR 5.10,P=0.040),用药后差异消失。
核心结论
- 哥伦比亚分型有助于预测日本FSGS患者的肾脏预后。
- 尖端型预后良好,塌陷型预后差,细胞型经激素/免疫抑制治疗可能获得良好临床病程。
研究设计与样本
- 多中心回顾性研究,从日本10个肾脏病中心提取201例FSGS患者。
- 复合肾脏终点定义为血肌酐翻倍和/或进展至终末期肾病。
- 采用敏感性分析验证哥伦比亚分型预测肾脏结局的效用。
主要发现
- 各变异型分布:非特殊型n=121(60.1%),门周型n=31(15.4%),细胞型n=19(9.5%),尖端型n=17(8.5%),塌陷型n=13(6.5%)。
- 尖端型无患者达到肾脏终点。
- 塌陷型肾脏结局显著差于非特殊型(HR 3.71,P=0.005)。
- 敏感性分析中,将哥伦比亚分型加入包含常见危险因素的模型后,肾脏终点的ROC曲线下面积增加(P=0.021)。
- 未用激素/免疫抑制亚组中,细胞型结局差于非特殊型(HR 5.10,P=0.040);用激素/免疫抑制亚组中差异未观察到(HR 0.54,P=0.539)。
关键数值与推荐
- 复合肾脏终点:血肌酐翻倍和/或进展至终末期肾病。
- 塌陷型 vs 非特殊型肾脏终点HR 3.71(P=0.005)。
- 细胞型 vs 非特殊型未用激素/免疫抑制亚组HR 5.10(P=0.040),用激素/免疫抑制亚组HR 0.54(P=0.539)。
- 加入哥伦比亚分型后ROC曲线下面积增加P=0.021。
临床怎么用
- 对FSGS患者进行哥伦比亚分型有助于风险分层和预后判断。
- 塌陷型患者预后差,应加强监测和干预。
- 细胞型患者若未接受激素/免疫抑制治疗预后较差,提示该亚型可能从激素/免疫抑制治疗中获益。
局限性
- 样本量较小(201例),部分变异型(如塌陷型n=13、尖端型n=17)例数少。
- 为回顾性研究,可能存在选择偏倚和信息偏倚。
- 激素/免疫抑制治疗的分析为亚组分析,非随机对照,不能确立因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The utility of the Columbia classification (Col-class) for focal segmental glomerulosclerosis (FSGS) has not yet been fully proven. METHODS: We extracted 201 FSGS patients from 10 nephrology centers in Japan and investigated the difference of a composite renal endpoint, defined as doubling of serum creatinine and/or development of end-stage renal disease, in pathological variants. Sensitivity analysis was used to prove the utility of the Col-class to predict renal outcomes. Additionally, the renal protective effects of steroids and/or immunosuppression (steroid/IS) were investigated in patients stratified according to the Col-class. RESULTS: The patients were classified into the following variants: not otherwise specified [NOS; n = 121 (60.1%)], perihilar [n = 31 (15.4%)], cellular [n = 19 (9.5%)], tip [n = 17 (8.5%)] and collapsing [n = 13 (6.5%)]. No tip variant patients reached the renal endpoint. The renal outcome in the collapsing variant was significantly poorer than that in the NOS [hazard ratio (HR) 3.71; P = 0.005]. In the sensitivity analysis, the area under the receiver operating characteristic curve for the renal endpoint was increased by adding Col-class to a model including common risk factors (P = 0.021). In a subgroup treated without steroid/IS, the outcome in the cellular variant was worse than that in the NOS (HR 5.10; P = 0.040) but the difference was not observed in the subgroup with steroid/IS (HR 0.54; P = 0.539). CONCLUSIONS: The Col-class is useful to predict renal prognosis in Japanese patients with FSGS. In addition to good prognosis in the tip variant and poor in the collapsing variant, good clinical course in the cellular variant treated with steroid/IS was suggested.
引用
- Tsuchimoto A, Matsukuma Y, Ueki K, et al. Utility of Columbia classification in focal segmental glomerulosclerosis: renal prognosis and treatment response among the pathological variants. Nephrol Dial Transplant. 2020. PMID: 30649467. doi:10.1093/ndt/gfy374
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。